School of Medicine


Showing 51-100 of 115 Results

  • Chia Sui Kao

    Chia Sui Kao

    Assistant Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Genitourinary tumors with a special interest in Testicular tumors

  • Richard Kempson

    Richard Kempson

    Professor of Pathology, Emeritus

    Current Research and Scholarly Interests Clinicopathologic studies in endometrial carcinoma, ovarian neoplasms, and soft tissue tumors.

  • Christina Kong

    Christina Kong

    Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Improving the accuracy of cytologic diagnosis through the use of ancillary techniques on specimens obtained by fine needle aspiration biopsy.

    Identifying potential indicators of prognosis in head and neck squamous cell carcinomas.

    Evaluating the utility of immunohistochemical stains in refining the diagnosis of squamous dysplasia of the cervix, vulva, and head and neck.

  • Jon Kosek

    Jon Kosek

    Professor (Clinical) of Pathology, Emeritus

    Current Research and Scholarly Interests Methods of evaluation of biopsies; differentiation and, classification of neoplasms; immunohistochemistry; scanning and, transmission electron microscopy; cardiovascular pathology;, histologic assessment of bone biopsies; heart preservation and, restoration; myocardial biopsies; venous autograft coronary artery, bypass; cardial and heart valve transplantation.

  • Christian Kunder

    Christian Kunder

    Clinical Assistant Professor, Pathology

    Current Research and Scholarly Interests My main interest is in understanding the biology of human neoplasms, using traditional histopathology, molecular genetic techniques, and other modalities. In particular, I am interested in soft tissue and genitourinary neoplasms, especially prostate cancer.

    I am also interested in the classification and nomenclature of neoplasms and in practical research that helps us refine these, using a variety of techniques but still principally guided by histopathology.

    I also work on developing next generation sequencing-based tests for genotyping tumors and in expanding the scope of this testing with the goal of identifying patients eligible for novel targeting therapies.

  • Joseph (Joe) Lipsick

    Joseph (Joe) Lipsick

    Professor of Pathology, of Genetics and, by courtesy, of Biology

    Current Research and Scholarly Interests Function and evolution of the Myb oncogene family; function and evolution of E2F transcriptional regulators and RB tumor suppressors; epigenetic regulation of chromatin and chromosomes; cancer genetics.

  • Alarice Cheng-Yi Lowe

    Alarice Cheng-Yi Lowe

    Associate Professor of Pathology at the Stanford University Medical Center

    Bio Dr. Lowe joined the School of Medicine faculty in 2019. She received her undergraduate degree in Biology from MIT and her medical degree at UCSD, prior to residency and cytology fellowship at UCLA. In 2011, she joined the faculty at Brigham and Women's Hospital where she developed a research focus on Circulating Tumor Cells (CTCs) and the application of CTC technology to improve clinical diagnostics. Clinically, her interests focus on Cytopathology and Genitourinary Pathology.

  • Bingwei Lu

    Bingwei Lu

    Professor of Pathology

    Current Research and Scholarly Interests We are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimer’s and Parkinson’s diseases. We are using both Drosophila and mammalian models to address these fundamental questions.

  • Joshua Menke

    Joshua Menke

    Clinical Assistant Professor, Pathology

    Bio Dr. Joshua Menke completed his hematopathology fellowship at Stanford and cytopathology fellowship at University of California San Francisco (UCSF). His clinical and research interests lie at the intersection of hematopathology, cytopathology and advanced single cell and cell free diagnostic techniques. As Associate Director of the Flow Cytometry lab at Stanford, Dr. Menke will be developing new minimal residual disease assays and Dr. Menke is the receipient of the Paul E. Standjord Young Investigator Award from the Academy of Clinical Laboratory Scientists and Laurance J. Marton Award for Excellence in Research from UCSF for his translational work on CALR mutations at the UCSF Molecular Diagnostics Laboroatory. Currently, he is spearheading novel genomic and proteomic analytic techniques to study cytology samples obtained for lymphoma diagnostics, including sequencing cell-free tumor DNA from supernatant samples. Dr. Menke is a founding member of the Cytology-Hematopathology Interinstitution Collaboration (CHIC) that aims to study the performance of cytology samples in diagnosing lymphoma across large datasets from five academic institutions.

  • Michelle Monje

    Michelle Monje

    Associate Professor of Neurology and, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests The Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.

  • Stephen B. Montgomery

    Stephen B. Montgomery

    Associate Professor of Pathology, and of Genetics

    Current Research and Scholarly Interests We focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with developing and utilizing state-of-the-art bioinformatics and statistical genetics approaches. See our website at http://montgomerylab.stanford.edu/

  • Thomas Montine

    Thomas Montine

    Stanford Medicine Pathology Professor

    Bio Dr. Montine received his education at Columbia University (BA in Chemistry), the University of Rochester (PhD in Pharmacology), and McGill University (MD and CM). His postgraduate medical training was at Duke University, and he was junior faculty at Vanderbilt University where he was awarded the Thorne Professorship in Pathology. In 2002, Dr. Montine was appointed as the Alvord Endowed Professor in Neuropathology and Director of the Division of Neuropathology at the University of Washington. He was Director of the University of Washington Alzheimer?s Disease Research Center, one of the original 10 Centers in the US, and passed that responsibility to able colleagues. In 2010, Dr. Montine was appointed Chair of the Department of Pathology at the University of Washington. In 2016, Dr. Montine was appointed Chair of the Department of Pathology at Stanford University where he is the Stanford Medicine Endowed Professor in Pathology.

    Dr. Montine is the founding Director of the Pacific Udall Center, one of 9 NINDS-funded Morris K. Udall Centers of Excellence for Parkinson?s Disease Research. Our center performs basic, translational, and clinical research focused on cognitive impairment in Parkinson?s disease. The Pacific Udall Center emphasizes a vision for precision health that comprises functional genomics, development of surveillance tools for pre-clinical detection, and discovery of molecularly tailored therapies.

    Dr. Montine is among the top recipients of NIH funding for all Department of Pathology faculty in the United States. He was the 2015 President of the American Association of Neuropathologists, and led or co-led recent NIH initiatives to revise diagnostic guidelines for Alzheimer?s disease (NIA), develop research priorities for the National Alzheimer?s Plan (NINDS and NIA), and develop research priorities for Parkinson?s Disease (NINDS).

    The focus of the Montine Laboratory is on the structural and molecular bases of cognitive impairment with the goal of defining key pathogenic steps and thereby new therapeutic targets. The Montine Laboratory addresses these prevalent, unmet medical needs through a combination of neuropathology, biomarker development and application early in the course of disease, and experimental studies that test hypotheses concerning specific mechanisms of neuron injury and approaches to neuroprotection. PubMed lists 579 publications for Dr. Montine. Google Scholar estimates Dr. Montine?s citations as > 38,000, his i-10 index as 355, and his H-Index as 98. NIH iCite calculates (1995 to 2017) Dr. Montine?s weighted relative citation ratio as 2041.

  • Roberto Novoa, MD

    Roberto Novoa, MD

    Clinical Associate Professor, Pathology

    Current Research and Scholarly Interests My research interests include the medical applications of artificial intelligence, cutaneous lymphoma, and the side effects of targeted therapies. I have served as the lead dermatologist in our ongoing effort to develop AI-augmented classification of skin lesions. We are in the process of establishing one of the first prospective studies examining the performance of a deep learning algorithm in real-world patients.

  • Michael G. Ozawa

    Michael G. Ozawa

    Clinical Assistant Professor, Pathology

    Bio Dr. Ozawa is a Clinical Assistant Professor of Pathology with subspecialty focus in Cytopathology, Head and Neck pathology, and Thoracic pathology. He completed his M.D., Ph.D. training at the McGovern Medical School and the M. D. Anderson Cancer Center in Houston, TX. He then completed residency training in Anatomic and Clinical Pathology followed by fellowship training in Surgical Pathology and Cytopathology at Stanford University. He is board certified in Anatomic and Clinical Pathology as well as Cytopathology. His interests include pulmonary neoplasms as well as neoplasms of the Head and Neck. He also has developed collaborative research interests in utilizing fine needle aspiration (FNA) techniques in the growing clinical application of Chimeric Antigen T Cell (CAR-T) therapy.

  • Tho Duc Pham

    Tho Duc Pham

    Clinical Assistant Professor, Pathology

    Current Research and Scholarly Interests My areas of interest involve exploring antibody function as it relates to transfusion medicine, blood safety, and emerging infectious diseases. This ranges from natural immune responses to the ABO blood group, antibody profiling anti-SARS-CoV-2 antibodies, and studying HEV seroprevalence in the local community. I am also interested in exploring statistical approaches to improve blood product availability and overall health care efficiency in a tertiary care system.

  • Benjamin Pinsky

    Benjamin Pinsky

    Associate Professor of Pathology and of Medicine (Infectious Diseases) and, by courtesy, of Pediatrics (Infectious Diseases) at the Stanford University Medical Center

    Current Research and Scholarly Interests Development and application of molecular assays for the diagnosis and management of infectious diseases.

  • Jonathan Pollack

    Jonathan Pollack

    Professor of Pathology

    Current Research and Scholarly Interests Research in the Pollack lab centers on translational genomics, with a focus on human cancer. The lab employs next-generation sequencing, single-cell genomics, genome editing, and cell/tissue-based modeling to uncover disease mechanisms, biomarkers and therapeutic targets. Current areas of emphasis include diseases of the prostate (prostate cancer and benign prostatic hyperplasia), as well as odontogenic neoplasms.

  • Donald Regula, MD

    Donald Regula, MD

    Professor (Teaching) of Pathology and, by courtesy, of Orthopaedic Surgery

    Bio Dr. Regula is a course director for the required medical student course, Science of Medicine.

  • Kerri E. Rieger, MD, PhD

    Kerri E. Rieger, MD, PhD

    Clinical Associate Professor, Pathology

    Bio Dr. Rieger is a Clinical Associate Professor of Pathology and Dermatology at Stanford University. She received her M.D., Ph.D. from Stanford University School of Medicine and completed her Dermatology Residency and Dermatopathology Fellowship at Stanford University. She is board certified in Dermatology and Dermatopathology. She evaluates skin specimens in the Pathology department, where her interests include histopathologic findings in hospitalized patients and patients with autoimmune disease. She also sees patients in the dermatology clinic at the Stanford Medicine Outpatient Center in Redwood City, where her clinical interest is adult general dermatology.

  • Darren Salmi

    Darren Salmi

    Clinical Assistant Professor, Surgery - Anatomy

    Current Research and Scholarly Interests Medical education, anatomy, autopsy, cardiovascular pathology

  • Neil Shah

    Neil Shah

    Clinical Associate Professor, Pathology

    Bio Dr. Shah is board certified in clinical pathology, transfusion medicine, and clinical informatics. His interests include the creation and use of rules-based and machine learning models from health data to help providers make better care decisions.

  • Jeanne Shen

    Jeanne Shen

    Assistant Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Gastrointestinal and pancreatobiliary pathology, with major emphasis on GI and pancreatic neoplasia, inflammatory bowel disease, biodesign innovation, and the application of machine learning to digital pathology.

  • Kang Shen

    Kang Shen

    Professor of Biology and of Pathology

    Current Research and Scholarly Interests The connectivity of a neuron (its unique constellation of synaptic inputs and outputs) is essential for its function. Neuronal connections are made with exquisite accuracy between specific types of neurons. How each neuron finds its synaptic partners has been a central question in developmental neurobiology. We utilize the relatively simple nervous system of nematode C. elegans, to search for molecules that can specify synaptic connections and understand the molecular mechanisms of synaptic as

  • Run Zhang Shi

    Run Zhang Shi

    Clinical Associate Professor, Pathology

    Current Research and Scholarly Interests Clinical chemistry and therapeutic drug monitoring;
    adult and pediatric clinical endocrine testing;
    screening, detection and follow up of multiple myeloma;
    tumor markers;
    clinical utility of tandem mass spectrometry and high resolution mass spectrometry.

  • Hiroyuki Shimada

    Hiroyuki Shimada

    Professor of Pathology and of Pediatrics at the Stanford University Medical Center

    Bio Hiroyuki Shimada, MD, PhD, FRCPA (Hon), is Professor of Pathology and of Pediatrics at the Stanford University Medical Center. He was born in Tokyo, Japan, and completed MD (1973) and PhD (1982) at the Yokohama City University School of Medicine, Yokohama, Japan, and also completed his pathology training at the Children's Hospital (now the Nationwide Children?s Hospital) and the Ohio State University, Columbus, Ohio, USA (1988). Before moving to the Stanford University in 2019, he was Professor of Pathology (Clinical Scholar) at the University of Southern California Keck School of Medicine and working at the Children?s Hospital Los Angeles.
    Dr. Shimada was Chair of the International Neuroblastoma Pathology Committee (1999-2017) and the founder of the International Neuroblastoma Pathology Classification (INPC). As Director of the COG (Children?s Oncology Group) Neuroblastoma Pathology Reference Laboratory (since 2001), he has been actively reviewing pathology samples of ~700 neuroblastoma cases per year from United States, Canada, Australia, and New Zealand. Pathology review results according to the INPC have been providing critical information for patient stratification and protocol assignment in the COG international neuroblastoma clinical trials.

  • Richard Sibley

    Richard Sibley

    Professor of Pathology

    Current Research and Scholarly Interests Immunologic mechanism of rejection in humans and animal, models of organ transplantation; histological definition of clinical pathology studies of various renal disorders.

  • Oscar Silva MD PhD

    Oscar Silva MD PhD

    Clinical Assistant Professor, Pathology

    Bio Dr. Oscar Silva is an academic hematopathologist who completed anatomic and clinical pathology residency and hematopathology fellowship at Stanford in 2020. Prior to Stanford, he received his MD and PhD from the University of California, Los Angeles ? California Institute of Technology Medical Scientist Training Program (UCLA-Caltech MSTP) and his B.A. from Santa Clara University. Dr. Silva strives to provide excellent patient care and medical student, resident and fellow education. His current interests include the diagnosis of difficult hematolymphoid neoplasms and the identification and characterization of markers of diagnostic and prognostic importance in hematolymphoid neoplasia.

  • Henning Stehr

    Henning Stehr

    Clinical Assistant Professor, Pathology

    Current Research and Scholarly Interests Bioinformatics & Clinical Cancer Genomics

  • David Steiner

    David Steiner

    Adjunct Clinical Assistant Professor, Pathology

    Current Research and Scholarly Interests Mechanistic and translational studies to better understand the functional and clinical implications of somatic mutations in aging and cancer.

  • Bryan Andrew Stevens

    Bryan Andrew Stevens

    Clinical Instructor, Pathology

    Bio Undergraduate - Ohio State University, 2011 - B.S. (Microbiology)
    Medical School - University of Toledo, 2015 - M.D.
    Residency - University of Pittsburgh Medical Center, 2019 - Anatomic/Clinical Pathology
    Fellowship - Stanford University, 2020 - Medical Microbiology

  • Carlos Jose Suarez Valencia

    Carlos Jose Suarez Valencia

    Clinical Assistant Professor, Pathology

    Bio Dr. Suarez is a board-certified pathologist specializing in anatomic, clinical and molecular genetic pathology. He received his M.D. degree with the highest honors (summa cum laude) from the University of the Valley (Universidad del Valle), Cali, Colombia. After medical school, he was a research fellow at a WHO-collaborating center investigating pattern of nosocomial antibiotic resistance, and later joined the University of California at San Diego (UCSD) as postdoctoral research fellow in cancer and lung immunology laboratories. He completed an anatomic and clinical pathology residency at the University of Washington, Seattle, and a Molecular Genetic Pathology fellowship at Stanford University. Dr. Suarez is currently Clinical Assistant Professor of Pathology at Stanford University, and he is also Co-Director of the Genetic and Genomic Testing Optimization Service and Associate Director of the Molecular Pathology Laboratory at the Stanford University Medical Center.

Footer Links:

Stanford Medicine Resources: